212 related articles for article (PubMed ID: 34558467)
1. Clinical, histopathological, and molecular characterization of leprosy in an endemic area of the colombian caribbean.
Fragozo-Ramos MC; Cano-Pérez E; Sierra-Merlano RM; Camacho-Chaljub F; Gómez-Camargo D
Int J Mycobacteriol; 2021; 10(2):155-161. PubMed ID: 34558467
[TBL] [Abstract][Full Text] [Related]
2. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico.
Han XY; Sizer KC; Velarde-Félix JS; Frias-Castro LO; Vargas-Ocampo F
Int J Dermatol; 2012 Aug; 51(8):952-9. PubMed ID: 22788812
[TBL] [Abstract][Full Text] [Related]
3. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore.
Han XY; Sizer KC; Tan HH
J Drugs Dermatol; 2012 Feb; 11(2):168-72. PubMed ID: 22270197
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium leprae and Mycobacterium lepromatosis Infection: a Report of Six Multibacillary Cases of Leprosy in the Dominican Republic.
Fernández JDP; Pou-Soarez VE; Arenas R; Juárez-Duran ER; Luna-Rojas SL; Xicohtencatl-Cortes J; Martínez-Chavarría LC; Martínez-Hernández F; Hernández-Castro R
Jpn J Infect Dis; 2022 Jul; 75(4):427-430. PubMed ID: 35354704
[TBL] [Abstract][Full Text] [Related]
5. Identification of
Torres-Guerrero E; Sánchez-Moreno EC; Atoche-Diéguez CE; Carrillo-Casas EM; Arenas R; Xicohtencatl-Cortes J; Hernández-Castro R
Ann Dermatol; 2018 Oct; 30(5):562-565. PubMed ID: 33911479
[TBL] [Abstract][Full Text] [Related]
6. Leprosy Caused by Mycobacterium lepromatosis.
Romero-Navarrete M; Arenas R; Han XY; Vega-Memije ME; Castillo-Solana AD
Am J Clin Pathol; 2022 Dec; 158(6):678-686. PubMed ID: 36200553
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis.
Collin SM; Lima A; Heringer S; Sanders V; Pessotti HA; Deps P
Emerg Infect Dis; 2023 Jul; 29(7):1376-1385. PubMed ID: 37347507
[TBL] [Abstract][Full Text] [Related]
8. Genomic characterization of Mycobacterium lepromatosis from ENL patients from India.
Singh I; Pathak VK; Lavania M; Ahuja M; Sharma R; Narang T; Jain S; Turankar RP; Dogra S; Sengupta U
Infect Genet Evol; 2023 Dec; 116():105537. PubMed ID: 38056703
[TBL] [Abstract][Full Text] [Related]
9. Isolation of Mycobacterium lepromatosis and Development of Molecular Diagnostic Assays to Distinguish Mycobacterium leprae and M. lepromatosis.
Sharma R; Singh P; McCoy RC; Lenz SM; Donovan K; Ochoa MT; Estrada-Garcia I; Silva-Miranda M; Jurado-Santa Cruz F; Balagon MF; Stryjewska B; Scollard DM; Pena MT; Lahiri R; Williams DL; Truman RW; Adams LB
Clin Infect Dis; 2020 Nov; 71(8):e262-e269. PubMed ID: 31732729
[TBL] [Abstract][Full Text] [Related]
10. Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis.
Silva FJ; Santos-Garcia D; Zheng X; Zhang L; Han XY
Microbiol Spectr; 2022 Jun; 10(3):e0169221. PubMed ID: 35467405
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium leprae: pathogenic agent in leprosy. Discovery of new species Mycobacterium lepromatosis. Perspectives in research and diagnosis of leprosy.
Kowalska M; Kowalik A
Int Marit Health; 2012; 63(4):213-8. PubMed ID: 24595978
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries.
Han XY; Aung FM; Choon SE; Werner B
Am J Clin Pathol; 2014 Oct; 142(4):524-32. PubMed ID: 25239420
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium lepromatosis as Cause of Leprosy, Colombia.
Cardona-Castro N; Escobar-Builes MV; Serrano-Coll H; Adams LB; Lahiri R
Emerg Infect Dis; 2022 May; 28(5):1067-1068. PubMed ID: 35450566
[TBL] [Abstract][Full Text] [Related]
14. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis.
Singh P; Benjak A; Schuenemann VJ; Herbig A; Avanzi C; Busso P; Nieselt K; Krause J; Vera-Cabrera L; Cole ST
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4459-64. PubMed ID: 25831531
[TBL] [Abstract][Full Text] [Related]
15. Severe leprosy reactions due to Mycobacterium lepromatosis.
Han XY; Jessurun J
Am J Med Sci; 2013 Jan; 345(1):65-9. PubMed ID: 23111393
[TBL] [Abstract][Full Text] [Related]
16. What is the evidence that the putative Mycobacterium lepromatosis species causes diffuse lepromatous leprosy?
Gillis TP; Scollard DM; Lockwood DN
Lepr Rev; 2011 Sep; 82(3):205-9. PubMed ID: 22125927
[TBL] [Abstract][Full Text] [Related]
17. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
[TBL] [Abstract][Full Text] [Related]
18. Effective amelioration of the Lucio phenomenon with adjuvant tofacitinib therapy in a patient with dual infection of
Patel NH; Padhiyar JK; Patel KA; Patel JR; Lakum MP; Singh I
Access Microbiol; 2023; 5(10):. PubMed ID: 37970083
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options.
Mungroo MR; Khan NA; Siddiqui R
Microb Pathog; 2020 Dec; 149():104475. PubMed ID: 32931893
[TBL] [Abstract][Full Text] [Related]
20. Lucio Leprosy with Lucio's phenomenon, digital gangrene and anticardiolipin antibodies.
Nunzie E; Ortega Cabrera LV; Macanchi Moncayo FM; Ortega Espinosa PF; Clapasson A; Massone C
Lepr Rev; 2014 Sep; 85(3):194-200. PubMed ID: 25509720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]